Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 462-468

  Sultan, Faisal ^a,c   Jin, Ling Ling ^a   Jobling, Michael G ^b   Holmes, Randall K ^b   Stanley Jr , Samuel L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMEBIASIS VACCINE; CHOLERA TOXIN; GANGLIOSIDE GM1; HYBRID PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MALTOSE BINDING PROTEIN; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; SERINE;

AMEBIASIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; ESCHERICHIA COLI; FEMALE; IMMUNOGENICITY; MUCOSAL IMMUNITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTOZOAL INFECTION; TOXIN ANALYSIS; VACCINATION;

EID: 0031908219     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.462-468.1998     Document Type: Article

References (31)

1. Bessen, D., and V. Fischetti. 1988. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect. Immun. 56:2666-2672.
2. Betley, M., V. Miller, and J. Mekalanos. 1989. Genetics of bacterial entero-toxins. Annu. Rev. Microbiol. 40:577-605.
3. Beving, D. E., C.-J. G. Soong, and J. I. Ravdin. 1996. Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity. Infect. Immun. 64:1473-1476.
4. Cuatrecasas, P. 1973. Gangliosides and membrane receptors for cholera toxin. Biochemistry 12:3558-3566.
5. Czerkinsky, C., L.-A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65: 109-121.
6. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. Holmgren. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1072-1077.
7. Czerkinsky, C., A.-M. Svennerholm, and J. Holmgren. 1993. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 16(Suppl. 2):S106-S116.
8. Dertzbaugh, M. T., and C. O. Elson. 1993. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect. Immun. 61:384-390.
9. Elson, C. O. 1989. Cholera toxin and its subunits as potential oral adjuvants. Curr. Top. Microbiol. Immunol. 146:29-33.
10. Elson, C. O., and W. Ealding. 1984. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133:2892-2897.
11. Elson, C. O., and W. Ealding. 1984. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2741.
12. Hajishengallis, G., S. K. Hollingshead, T. Koga, and M. W. Russell. 1995. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J. Immunol. 154:4322-4332.
13. Hajishengallis, G., S. M. Michalek, and M. W. Russell. 1996. Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect. Immun. 64:665-667.
14. Jobling, M. G., and R. K. Holmes. 1992. Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras. Infect. Immun. 60:4915-4924.
15. Li, T. K., and B. S. Fox. 1996. Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T-cell clone. Int. Immunol. 8:1849-1856.
16. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholera and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
17. McKenzie, S. J., and J. F. Halsey. 1984. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immunol. 133:1818-1824.
18. Meza, I., F. Cazares, J. L. Rosales-Encina, P. Talamas-Rohana, and M. Rojkind. 1987. Use of antibodies to characterize a 220-kilodalton surface protein from Entamoeba histolytica. J. Infect. Dis. 156:798-805.
19. Myung, K., D. Burch, T. F. H. G. Jackson, and S. L. Stanley, Jr. 1992. Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica antigen-based ELISA. Arch. Med. Res. 23:285-288.
20. Ravdin, J. I., W. A. Petri, Jr., C. F. Murphy, and R. D. Smith. 1986. Production of mouse monoclonal antibodies which inhibit in vitro adherence of Entamoeba histolytica trophozoites. Infect. Immun. 53:1-5.
21. Russell, M. W., and H. Wu. 1991. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect. Immun. 59:4061-4070.
22. Sanchez, J. L., A. F. Trofa, D. N. Taylor, R. A. Kuschner, R. F. DeFraites, S. C. Craig, M. R. Rao, J. D. Clemens, A.-M, Svennerholm, J. C. Sadoff, and J. Holmgren. 1993. Safety and immunogenicity of the oral, whole cell recombinant B subunit cholera vaccine in North American volunteers. J. Infect. Dis. 167:1446-1449.
23. Snider, D. P. 1995. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit. Rev. Immunol. 15:317-348.
24. Stanley, S. L., Jr., A. Becker, C. Kunz-Jenkins, L. Foster, and E. Li. 1990. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats. Proc. Natl. Acad. Sci. USA 87:4976-4980.
25. Stanley, S. L., Jr., H. Huizenga, and E. Li. 1992. Isolation and partial characterization of a surface glycoconjugate of Entamoeba histolytica. Mol. Biochem. Parasitol. 50:127-138.
26. Stanley, S. L., Jr., K. Tian, J. P. Koester, and E. Li. 1995. The serine rich Entamoeba histolytica protein (SREHP) is a phosphorylated membrane protein containing O-linked terminal N-acetylglucosamine (O-GlcNAc) residues. J. Biol. Chem. 270:4121-4126.
27. Svennerholm, A.-M., M. Jertborn, L. Gothefors, A. M. M. M. Karim, D. A. Sack, and J. Holmgren. 1984. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J. Infect. Dis. 149:884-893.
28. Zhang, T., P. R. Cieslak, L. Foster, C. Kunz-Jenkins, and S. L. Stanley, Jr. 1994. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol. 16:225-230.
29. Zhang, T., P. R. Cieslak, and S. L. Stanley, Jr. 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen. Infect. Immun. 62:1166-1170.
30. Zhang, T., E. Li, and S. L. Stanley, Jr. 1995. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect. Immun. 63:1349-1355.
31. Zhang, T., and S. L. Stanley, Jr. 1996. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein (SREHP) induces an anti-amebic immune response and protects gerbils from amebic liver disease. Infect. Immun. 64: 1526-1531.